This inventor holds 4 USPTO granted patents. Top assignees: Ferring Ab, Ferring B.v.. Active years: 1996-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Malmo, SE (1996)
- Bunkeflostrand, SE (1997 - 1999)
Company Filing History:
Years Active: 1996-1999
Title: Birgitta Mornstam: Innovator in Pharmaceutical Development
Introduction
Birgitta Mornstam is a notable inventor based in Bunkeflostrand, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of desmopressin, a medication used for various medical conditions. With a total of 4 patents to her name, Mornstam's work has had a considerable impact on the treatment of nocturia, incontinence, and diabetes insipidus.
Latest Patents
Mornstam's latest patents include innovative processes for the manufacture of high purity desmopressin. One of her patents focuses on a method for treating nocturia, incontinence, and enuresis using high purity desmopressin produced in substantial single batches. Another patent addresses the treatment of diabetes insipidus with the same high purity desmopressin, showcasing her commitment to improving patient care through advanced pharmaceutical techniques.
Career Highlights
Throughout her career, Mornstam has worked with prominent companies in the pharmaceutical industry, including Ferring B.V. and Ferring AB. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research and development in her field.
Collaborations
Mornstam has collaborated with esteemed colleagues such as Krister Larsson and Jan Roschester. These partnerships have fostered a collaborative environment that has led to innovative solutions in pharmaceutical development.
Conclusion
Birgitta Mornstam's contributions to the field of pharmaceuticals, particularly through her patents on desmopressin, highlight her role as a leading inventor. Her work continues to influence the treatment of various medical conditions, making her a significant figure in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
